Literature DB >> 2066358

The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas.

H Ostmeier1, J Schumann, F Otto, V Krieg, B Fuchs, B Biess, G Burg, L Suter.   

Abstract

Sex is a well proven prognosticator in primary malignant melanoma. We studied 19 parameters of tumor cells in primary malignant melanoma from 391 patients, the purpose being to determine if melanomas in men and women are alike. Apart from results in thin melanomas, no difference was seen between the sex groups. Thin melanomas showed a significant difference for the melanoma-associated antigen G7-E2 (higher expression in women) and the histocompatibility antigen HLA-DR (higher expression in men). The results suggest that sex-related prognostic differences are due more to host than to tumor characteristics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066358     DOI: 10.1007/BF01630721

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  18 in total

1.  Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.

Authors:  M Herlyn; D Guerry; H Koprowski
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

2.  A monoclonal antibody specific for cells of the melanocyte lineage.

Authors:  C Vennegoor; P Hageman; H Van Nouhuijs; D J Ruiter; J Calafat; P J Ringens; P Rümke
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

3.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

4.  Low- and high-risk malignant melanoma--I. Evaluation of clinical and histological prognosticators in 585 cases.

Authors:  C Schmoeckel; A Bockelbrink; H Bockelbrink; J Koutsis; O Braun-Falco
Journal:  Eur J Cancer Clin Oncol       Date:  1983-02

5.  A tumor-associated antigen expressed in melanoma cells with lower malignant potential.

Authors:  L Suter; J Brüggen; E B Bröcker; C Sorg
Journal:  Int J Cancer       Date:  1985-06-15       Impact factor: 7.396

6.  Survival and prognostic factors of patients with skin melanoma. A regression-model analysis based on nationwide cancer registry data.

Authors:  S Karjalainen; T Hakulinen
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

7.  Phenotypic dynamics of tumor progression in human malignant melanoma.

Authors:  E B Bröcker; L Suter; J Brüggen; D J Ruiter; E Macher; C Sorg
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

8.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

9.  The Ki-67 antigen in primary human melanomas--its relationship to mitotic rate and tumor thickness and its stability.

Authors:  H Ostmeier; L Suter
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

10.  In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89.

Authors:  B Holzmann; J P Johnson; P Kaudewitz; G Riethmüller
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.